Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial.
Ties D, van Dorp P, Pundziute G, van der Aalst CM, Gratama JWC, Braam RL, Kuijpers D, Lubbers DD, van der Bilt IAC, Westenbrink BD, Wolcherink MJO, Doggen CJM, Išgum I, Nijveldt R, de Koning HJ, Vliegenthart R, Oudkerk M, van der Harst P. Ties D, et al. Among authors: nijveldt r. Am Heart J. 2022 Apr;246:166-177. doi: 10.1016/j.ahj.2022.01.005. Epub 2022 Jan 14. Am Heart J. 2022. PMID: 35038412 Free article. Clinical Trial.
Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
Hirsch A, Nijveldt R, van der Vleuten PA, Biemond BJ, Doevendans PA, van Rossum AC, Tijssen JG, Zijlstra F, Piek JJ; HEBE investigators. Hirsch A, et al. Among authors: nijveldt r. Am Heart J. 2006 Sep;152(3):434-41. doi: 10.1016/j.ahj.2006.02.007. Am Heart J. 2006. PMID: 16923409
Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
Hirsch A, Nijveldt R, van der Vleuten PA, Tijssen JG, van der Giessen WJ, Tio RA, Waltenberger J, ten Berg JM, Doevendans PA, Aengevaeren WR, Zwaginga JJ, Biemond BJ, van Rossum AC, Piek JJ, Zijlstra F; HEBE Investigators. Hirsch A, et al. Among authors: nijveldt r. Eur Heart J. 2011 Jul;32(14):1736-47. doi: 10.1093/eurheartj/ehq449. Epub 2010 Dec 10. Eur Heart J. 2011. PMID: 21148540 Clinical Trial.
A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction.
van der Laan AM, Hirsch A, Robbers LF, Nijveldt R, Lommerse I, Delewi R, van der Vleuten PA, Biemond BJ, Zwaginga JJ, van der Giessen WJ, Zijlstra F, van Rossum AC, Voermans C, van der Schoot CE, Piek JJ. van der Laan AM, et al. Among authors: nijveldt r. Am Heart J. 2012 Jan;163(1):57-65.e2. doi: 10.1016/j.ahj.2011.09.002. Epub 2011 Nov 23. Am Heart J. 2012. PMID: 22172437 Free article.
Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage.
Robbers LF, Eerenberg ES, Teunissen PF, Jansen MF, Hollander MR, Horrevoets AJ, Knaapen P, Nijveldt R, Heymans MW, Levi MM, van Rossum AC, Niessen HW, Marcu CB, Beek AM, van Royen N. Robbers LF, et al. Among authors: nijveldt r. Eur Heart J. 2013 Aug;34(30):2346-53. doi: 10.1093/eurheartj/eht100. Epub 2013 Apr 17. Eur Heart J. 2013. PMID: 23594591
Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial.
Lexis CP, van der Horst IC, Lipsic E, Wieringa WG, de Boer RA, van den Heuvel AF, van der Werf HW, Schurer RA, Pundziute G, Tan ES, Nieuwland W, Willemsen HM, Dorhout B, Molmans BH, van der Horst-Schrivers AN, Wolffenbuttel BH, ter Horst GJ, van Rossum AC, Tijssen JG, Hillege HL, de Smet BJ, van der Harst P, van Veldhuisen DJ; GIPS-III Investigators. Lexis CP, et al. JAMA. 2014 Apr 16;311(15):1526-35. doi: 10.1001/jama.2014.3315. JAMA. 2014. PMID: 24687169 Clinical Trial.
Long term outcome after mononuclear bone marrow or peripheral blood cells infusion after myocardial infarction.
Delewi R, van der Laan AM, Robbers LF, Hirsch A, Nijveldt R, van der Vleuten PA, Tijssen JG, Tio RA, Waltenberger J, Ten Berg JM, Doevendans PA, Gehlmann HR, van Rossum AC, Piek JJ, Zijlstra F; HEBE investigators. Delewi R, et al. Among authors: nijveldt r. Heart. 2015 Mar;101(5):363-8. doi: 10.1136/heartjnl-2014-305892. Epub 2014 Oct 7. Heart. 2015. PMID: 25294647 Clinical Trial.
The relationship between terminal QRS distortion on initial ECG and final infarct size at 4months in conventional ST- segment elevation myocardial infarct patients.
Hassell ME, Delewi R, Lexis CP, Smulders MW, Hirsch A, Wagner G, Bekkers SC, van der Horst IC, Zijlstra F, van Rossum AC, Piek JJ, van der Harst P, Nijveldt R. Hassell ME, et al. Among authors: nijveldt r. J Electrocardiol. 2016 May-Jun;49(3):292-9. doi: 10.1016/j.jelectrocard.2016.03.009. Epub 2016 Mar 5. J Electrocardiol. 2016. PMID: 27040921 Free article.
Right Ventricular Function After Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the Glycometabolic Intervention as Adjunct to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction III Trial).
Gorter TM, Lexis CP, Hummel YM, Lipsic E, Nijveldt R, Willems TP, van der Horst IC, van der Harst P, van Melle JP, van Veldhuisen DJ. Gorter TM, et al. Among authors: nijveldt r. Am J Cardiol. 2016 Aug 1;118(3):338-44. doi: 10.1016/j.amjcard.2016.05.006. Epub 2016 May 14. Am J Cardiol. 2016. PMID: 27265672 Free article.
273 results